homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

July 30, 2020

Curi Bio

Seattle-based Curi Bio acquired Dana Solutions, a developer of artificial intelligence and machine learning software for in vitro cell-based assays. Palo Alto, California-based Dana sells PhenoLearn, which models cell and tissue phenotypes, and Pulse, which analyzes cell contractions in the heart. It also has FDA funding to validate PhenoTox, which assesses the safety of medicines. Financial terms of the deal were not disclosed. Curi Bio develops human stem cell-based biotechnology products. It recently changed its name from NanoSurface Biomedical.




Email or user name:
Password:
 
Forgot password? Click here.